http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-560673-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-16 |
| filingDate | 1968-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1975-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CH-560673-A5 |
| titleOfInvention | Alkanolamine derivs beta-adrenergic blocking agents |
| abstract | (A) Alkanolamine derivs. of general formula (I): R1 = H or alkyl opt. substd. by one or more hydroxy, alkoxy, aryl and/or aryloxy (the aryl and aryloxy groups may themselves be substd. with one or more halogen, alkyl and/or alkoxy groups); cycloalkyl or alkenyl; R2 = acyl such as those derived from carboxylic- or sulphonic acids; R3 = alkyl (pref. max C10); R4 and R5 are same or different H or alkyl (max C4). (B) Esters, aldehyde-condensation products and acid addition salts of (I). (C) Unspecified 4-acylamino-2-alkylphenols and 2-alkyl-4-aminophenols (new intermediate products). (I) Are beta-adrenergic blocking agents and may be used in the treatment of heart diseases such as angina pectoris, cardial arrhythmia as well as hypertension and phaeochromocytomie in man. |
| priorityDate | 1968-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.